Wyden Statement on Trump Drug Pricing Announcement

Wyden Statement on Trump Drug Pricing Announcement

Washington, D.C. - Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued the following statement after Trump invited the CEO of Pfizer to the White House to make an announcement about the price of prescription drugs.

"Once again, Donald Trump is slapping his name on a shoddy product with too-good-to-be-true benefits and expecting his followers to come running," Wyden said. "Once again, too many Americans living on a fixed income will fall victim to Trump's false promises and be worse off for it. Trump's announcement, made arm in arm with Big Pharma, is about as real as his pledge to give every American a MedBed."

"The only question Americans need to ask themselves is whether Trump has ever actually lowered their drug costs. The fact is Trump and Republicans handed billions in bailouts to Big Pharma in their partisan tax bill, cementing higher prices on life-savings cancer drugs, like Keytruda and Opdivo that were due to be negotiated next year through the law Democrats passed without a single Republican vote."

###